Brokerage houses have issued fresh notes on several frontline stocks based on earnings reports, operational updates, and regulatory actions. Here are key stocks to watch today, April 16, 2025, based on the latest brokerage views:
IndusInd Bank
Macquarie: Outperform, Target Price ₹1,210
-
Derivative-related discrepancies estimated to impact net worth by 2.27%, marginally below internal assessments.
-
Brokerage sees this as incrementally positive in the near term.
Morgan Stanley: Equal-weight, TP ₹755
-
External audit findings confirm loss impact largely in line with previous estimates (2.35% of F3Q25 net worth).
-
Awaiting full audit report and Q4 earnings to evaluate further implications.
Citi: Buy, TP ₹890
-
External review pegs post-tax hit at ₹1,979 crore (2.27% of net worth).
-
Citi notes modest earnings and considers MD/CEO transition as a key monitorable going ahead.
Mahanagar Gas (MGL), Indraprastha Gas (IGL), ONGC
CLSA on Oil & Gas Sector
-
IGL and MGL have seen an 18–20% reduction in cheaper domestic gas allocation for CNG use.
-
This will be replaced with new well gas priced ~20% higher, implying an estimated ₹0.6/kg hike in CNG prices to maintain margins.
-
ONGC stands to benefit, as the share of higher-priced new well gas rises from 11% to 17% of its standalone output.
Jefferies on MGL: Underperform, TP ₹1,220
-
New gas mix (with 30% premium) unlikely to be fully passed on despite recent hikes in CNG/PNG.
-
Builds in flat EPS over FY25–27E due to strong volume growth but lower margins.
ICICI Prudential Life
Morgan Stanley: Equal-weight, TP cut to ₹600
-
APE growth cut due to slowing ULIPs; group credit mortality assumptions impacted Embedded Value.
-
VNB forecasts trimmed due to slower margin recovery.
Nomura: Neutral, TP ₹650
-
VNB margins improved to 22.7%, but APE declined 3% YoY; no major growth catalyst seen.
Citi: Neutral, TP cut to ₹650
-
Slower growth in ULIPs and non-linked savings, reduced protection margins, and mortality assumption concerns.
-
Persistency issues in select segments led to a 2–4% cut in FY26–28E Embedded Value.
Jefferies: Buy, TP cut to ₹670
-
VNB at ₹8bn (+2% YoY) ahead of expectations, but margins dropped due to mortality and cost assumptions.
-
Trimmed VNB estimate by 6%, sees 14% CAGR over FY25–28.
Nuvama: Upgrade to Buy from Hold, TP cut to ₹680
-
Total APE grew 15% YoY; VNB margin stable at 22.7%.
-
VNB increased 2.4% YoY to ₹8bn in Q4FY25.
ICICI Lombard
Morgan Stanley: Downgrade to Equal-weight, TP cut to ₹1,855
-
PAT missed estimates due to weak underwriting and low investment income.
-
Sees limited upside due to rich valuations and tepid growth.
Jefferies: Buy, TP cut to ₹2,170
-
Q4 profit at ₹5.1bn, down 2% YoY, missed estimates on weak operating and investment income.
-
Trimmed FY26E EPS by ~6%, cites competition in motor segment as key concern.
Nuvama: Buy, TP cut to ₹2,100 from ₹2,400
-
GWP growth muted at 10.2% YoY; loss ratio rose but was offset by lower expenses.
-
APAT declined 1.9% YoY and nearly 30% QoQ.
Aditya Birla Real Estate
Nomura: Buy, TP ₹2,700
-
Q4 presales at ₹5,700 crore (+96% YoY), driven by strong performance in Birla Arika, Gurugram, and Bengaluru launches.
-
FY25 presales stood at ₹8,000 crore (+101% YoY), at the top-end of guidance.
-
Eight launches planned in FY26, including the third tower at Niyaara, Worli.
Disclaimer: The above views are of the broker’s and not the author or the publication’s. Please make any and every investment decision after consulting your financial advisor.
